The COVID-19 Epidemic in Madagascar: clinical description and laboratory
results of the first wave, March-September 2020
Abstract
Background: Following the first detection of SARS-CoV-2 in passengers
arriving from Europe on 19 March 2020, Madagascar took several
mitigation measures to limit the spread of the virus in the country.
Methods: Nasopharyngeal and/or oropharyngeal swabs were collected from
travellers to Madagascar, suspected SARS-CoV-2 cases, and contact of
confirmed cases. Swabs were tested at the national reference laboratory
using real-time RT-PVR. Data collected from patients were entered in an
electronic database for subsequent statistical analysis. All
distribution of laboratory confirmed cases were mapped and six genomes
of viruses were fully sequenced. Results: Overall, 26,415 individuals
were tested for SARS-CoV-2 between 18 March and 18 September 2020, of
whom 21.0% (5,553/26,145) returned positive. Among laboratory-confirmed
SARS-CoV-2 positive patients, the median age was 39 years (CI95%:
28-52), and 56.6% (3,311/5,553) were asymptomatic at the time of
sampling. The probability of testing positive increased with age with
the highest adjusted odds ratio of 2.2 [95% CI: 1.9-2.5] for
individuals aged 49 years and more. Viral strains sequenced belong to
clades 19A, 20A, and 20B in favour of several independent introduction
of viruses. Conclusions. Our study describes the first wave of the
COVID-19 in Madagascar. Despite early strategies in place Madagascar
could not avoid the introduction and spread of the virus. More studies
are needed to estimate the true burden of disease and make public health
recommendations for a better preparation to another wave.